Compass Therapeutics, Inc. (CMPX)
0.9912
+0.01
(+0.79%)
USD |
NASDAQ |
Oct 09, 16:00
0.9912
0.00 (0.00%)
After-Hours: 17:34
Compass Therapeutics EPS Diluted (Quarterly) : -0.1347 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1347 |
| March 31, 2026 | -0.0983 |
| December 31, 2025 | -0.085 |
| September 30, 2025 | -0.0845 |
| June 30, 2025 | -0.1438 |
| March 31, 2025 | -0.1203 |
| December 31, 2024 | -0.109 |
| September 30, 2024 | -0.0762 |
| June 30, 2024 | -0.095 |
| March 31, 2024 | -0.079 |
| December 31, 2023 | -0.1051 |
| September 30, 2023 | -0.0782 |
| June 30, 2023 | -0.089 |
| March 31, 2023 | -0.062 |
| December 31, 2022 | -0.10 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.1186 |
| June 30, 2022 | -0.0841 |
| March 31, 2022 | -0.071 |
| December 31, 2021 | -0.1287 |
| September 30, 2021 | -0.0968 |
| June 30, 2021 | -1.075 |
| March 31, 2021 | -0.1446 |
| December 31, 2020 | -0.161 |
| September 30, 2020 | -0.1756 |
| June 30, 2020 | -0.1066 |
| March 31, 2020 | -0.1228 |
| December 31, 2019 | -0.1269 |
| September 30, 2019 | -0.1641 |
| June 30, 2019 | -0.169 |
| March 31, 2019 | -0.2067 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viking Therapeutics, Inc. | -1.101 |
| Capricor Therapeutics, Inc. | -0.7032 |
| Ardelyx, Inc. | -0.0674 |
| Biomea Fusion, Inc. | -0.1151 |
| ARS Pharmaceuticals, Inc. | -0.6277 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.15M |
| Total Expenses (Quarterly) | 25.15M |
| Enterprise Value | 6.852M |
| Earnings Yield | -40.61% |
| Normalized Earnings Yield | -40.60 |